Recent FDA Approvals in Hematology/Oncology (Enduring 2025)

In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

 

image

 

Program Description: DCI APP Chemotherapy Prescribing Lecture Series 2025 (Enduring) Core requirements for qualification to prescribe chemotherapy for advances practice providers and clinical pharmacists' providers.

Target Audience

Nurse Practitioners

Physician Assistants

Physician's

Pharmacists

Learning Objectives

  1. Identifying new FDA-approved oncology medications for use in the management of hematologic or solid tumor malignancies
  2. Reviewing mechanisms of action, dosing, and toxicities of these medications
  3. Evaluating the place in therapy of the newly approved agents
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
10/02/2025
Registration Expires: 
10/02/2027
Part of: 
DCI-Advanced Practice Provider Lecture Series 2025 Enduring
Rating: 
0

Erin Eberwein

ACPE - Pharmacist

AMA PRA Category 1 Credit(s)

ANCC

JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.